Home - National Multiple Sclerosis Society

Skip to navigation Skip to content
National MS Society

Email not displaying correctly? View it in your browser.
eNews August 2011 - National MS Society
Phase III trial results for 2 new MS drugs

Alemtuzumab and laquinimod results released

Sanofi and its subsidiary Genzyme announced the results of a two-year study of 581 people with relapsing-remitting MS testing their experimental intravenous therapy alemtuzumab. Meanwhile, Teva Pharmaceutical Industries Ltd. and Active Biotech announced the results of a study involving more than 1,300 people with relapsing-remitting MS testing their oral drug laquinimod. Both companies say they hope to submit applications to the FDA in 2012.

Read the alemtuzumab results

Read the laquinimod results

Donate Now 

 Find us on Facebook 

YouTube MySpace Twitter

eNews Meet Heading

Lyn Laielli and Lyn's Leggs ride for MS

Lyn Laielli and Lyn's Leggs ride for MS

The NEW Momentum on the web or via your mobile device

The NEW Momentum on the web or via your mobile device
Join Phil Keoghan NOW as an MS Research Champion Join Phil Keoghan NOW as an MS Research Champion

The National MS Society has committed to raise $250 million for MS research through the NOW initiative, aiming to STOP MS in its tracks, RESTORE lost function and END the disease forever. To achieve this bold goal, we need everyone in the MS movement to stand together so that no opportunity is wasted and all promising research paths are followed. Join MS Ambassador and Research Champion Phil Keoghan of “The Amazing Race,” by becoming an MS Research Champion today.

Become an MS Research Champion


Grammy-nominated Drake raps for MSGrammy-nominated Drake raps for MS 

After selling out his phenomenally popular OVO Festival in Toronto last month, platinum-selling rapper Drake kicked off a North American tour this month, with a portion of all ticket sales going to the U.S. and Canadian MS Societies. Drake’s business partner and producer, Noah “40” Shebib, lives with MS.

Read more

More MS News 

July 27: Progress in managing MS symptoms and other results reported at CMSC Annual Meeting

July 15: FDA issues warning about medications containing oxybutynin

July 12: Bone health is a concern in early MS

Read more about these and other recent reports

This communication is partially sponsored through the generous support of Biogen Idec;
EMD Serono and Pfizer, Inc; Novartis Pharmaceuticals Corporation; and Teva Neuroscience, Inc.

MS Active Source  MS LifeLinesNovartis Teva Neuroscience

Join a Walk MS Event       Join a Bike MS Event      Shop at the Society Store

National MS Society | View as Web page | Subscribe | Legal Notice/Privacy Policy | Email Preferences | Unsubscribe

MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS.

Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please
visit our Web site.

Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.

National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017

This message was sent to  .
To ensure that you continue to receive our emails, please add us to your address book.